Global Monoclonal Antibodies (mAbs) Market North America Latest 2030

The Global Monoclonal Antibodies (mAbs) Market value is projected to reach US$ 309.47 Bn. at the end of the forecast period and it is expected to grow at the CAGR of 7 %.

The growth is coupled with Increasing R&D activities in genomics coupled with the advent of technologically advanced genetic platforms, such as next-generation sequencing, pose as the major drivers. In addition, the cost-effective nature of the technology is supporting its incorporation in performing research studies to develop mAbs. These are widely accepted biologics and are expected to present a billion-dollar opportunity to pharmaceutical manufacturers over the forecast period.